These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16465160)

  • 1. Designer combination therapy for cancer.
    Lane D
    Nat Biotechnol; 2006 Feb; 24(2):163-4. PubMed ID: 16465160
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and immunotherapeutic targeting of antigens induced by chemotherapy.
    Rubinfeld B; Upadhyay A; Clark SL; Fong SE; Smith V; Koeppen H; Ross S; Polakis P
    Nat Biotechnol; 2006 Feb; 24(2):205-9. PubMed ID: 16444269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy.
    Bhattacharya A; Tóth K; Mazurchuk R; Spernyak JA; Slocum HK; Pendyala L; Azrak R; Cao S; Durrani FA; Rustum YM
    Clin Cancer Res; 2004 Dec; 10(23):8005-17. PubMed ID: 15585636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are targeted therapies really targeted?
    Schilsky RL
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):722-3. PubMed ID: 16258475
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of colorectal carcinoma: standard chemotherapy and beyond.
    Eng C; Abbruzzese JL
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):592-8. PubMed ID: 16163242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal antibodies as antineoplastic antibodies].
    Hashimoto Y
    Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic antitumor activity of cetuximab and namitecan in human squamous cell carcinoma models relies on cooperative inhibition of EGFR expression and depends on high EGFR gene copy number.
    De Cesare M; Lauricella C; Veronese SM; Cominetti D; Pisano C; Zunino F; Zaffaroni N; Zuco V
    Clin Cancer Res; 2014 Feb; 20(4):995-1006. PubMed ID: 24327272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetuximab in colon cancer.
    Costa AF; Sander GB; Picon PD
    N Engl J Med; 2004 Oct; 351(15):1575-6; author reply 1575-6. PubMed ID: 15473024
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor immunology top 10 list.
    Finn OJ
    Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
    [No Abstract]   [Full Text] [Related]  

  • 11. Cetuximab in colon cancer.
    Martin MJ
    N Engl J Med; 2004 Oct; 351(15):1575-6; author reply 1575-6. PubMed ID: 15473023
    [No Abstract]   [Full Text] [Related]  

  • 12. New treatment options for colorectal cancer.
    Erlichman C; Sargent DJ
    N Engl J Med; 2004 Jul; 351(4):391-2. PubMed ID: 15269321
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
    Shapira S; Lisiansky V; Arber N; Kraus S
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress of chemotherapy in colorectal cancer].
    Komatsu Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1771-6. PubMed ID: 18064761
    [No Abstract]   [Full Text] [Related]  

  • 15. The price tag on progress--chemotherapy for colorectal cancer.
    Schrag D
    N Engl J Med; 2004 Jul; 351(4):317-9. PubMed ID: 15269308
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic therapy for squamous cell carcinoma of the head and neck.
    Pancari P; Mehra R
    Surg Oncol Clin N Am; 2015 Jul; 24(3):437-54. PubMed ID: 25979393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a case.
    Phan LK; Hoff PM
    Dis Colon Rectum; 2007 Mar; 50(3):395-8. PubMed ID: 17252287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
    Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
    Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future of immunotherapy drug combinations and biomarkers.
    Schmidt C
    J Natl Cancer Inst; 2012 Mar; 104(6):434-9. PubMed ID: 22402694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.